Montana Code 50-32-232. Specific dangerous drugs included in Schedule V
50-32-232. Specific dangerous drugs included in Schedule V. Schedule V consists of the drugs and other substances, by whatever official, common, usual, chemical, or brand name designated, listed in this section.
Terms Used In Montana Code 50-32-232
- Narcotic drug: means any of the following, whether produced directly or indirectly by extraction from substances of vegetable origin, independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
(a)opium and opiate and a salt, compound, derivative, or preparation of opium or opiate;
(b)a salt, compound, isomer, derivative, or preparation of a salt, compound, isomer, or derivative that is chemically equivalent or identical with any of the drugs referred to in subsection (19)(a), but not including the isoquinoline alkaloids of opium;
(c)opium poppy and poppy straw; or
(d)coca leaves and a salt, compound, derivative, or preparation of coca leaves and a salt, compound, isomer, derivative, or preparation of a salt, compound, isomer, or derivative that is chemically equivalent or identical with any of these drugs, but not including decocainized coca leaves or extractions of coca leaves that do not contain cocaine or ecgonine. See Montana Code 50-32-101
- Usual: means according to usage. See Montana Code 1-1-206
(1)Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following is a narcotic drug, including its salts, calculated as the free anhydrous base or alkaloid in limited quantities as set forth in subsections (1)(a) through (1)(f), which include one or more nonnarcotic, active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone:
(a)not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
(b)not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;
(c)not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;
(d)not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;
(e)not more than 100 milligrams of opium per 100 milliliters or per 100 grams; and
(f)not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.
(2)Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of pyrovalerone is a stimulant having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers.
(3)Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances is a depressant having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers:
(a)lacosamide, also known as (R)-2-acetoamido-N-benzyl-3-methoxy-propionamide or vimpat; and
(b)pregabalin, also known as (S)-3-(aminomethyl)-5-methylhexanoic acid or lyrica.
(4)Anticonvulsant substances include the following:
(a)ezogabine;
(b)brivaracetam;
(c)cenobamate; and
(d)ganaxalone.
(5)Antimigraine substances including lasmiditan.